Literature DB >> 19111028

The Persian Bipolar Spectrum Diagnostic Scale and mood disorder questionnaire in screening the patients with bipolar disorder.

Amir Shabani1, Laleh Koohi-Habibi, Marzieh Nojomi, Narges Chimeh, S Nassir Ghaemi, Naser Soleimani.   

Abstract

BACKGROUND: Considering the difficulties in diagnosing bipolar disorder in clinical practice and lack of needed screening instruments in Persian language, the present study aimed at assessing sensitivity, specificity, and predictive values for the Persian Bipolar Spectrum Diagnostic Scale.
METHODS: The study was conducted in a university-affiliated hospital in Tehran, Iran, in a sample of 181 consecutive outpatients aged 18-65 years. The used instruments were the Structured Clinical Interview for DSM-IV axis I disorders, the Persian Bipolar Spectrum Diagnostic Scale, the Persian Mood Disorder Questionnaire, and the Scale to Assess Unawareness of Mental Disorder.
RESULTS: Most patients were males (58%) and had bipolar I disorder (57%). Other bipolar disorders and major depressive disorder were diagnosed as 5.5% and 21%, respectively. Test-retest of the Persian Bipolar Spectrum Diagnostic Scale and Mood Disorder Questionnaire demonstrated a good reliability for both. The sensitivity, specificity, and positive and negative predictive values of the Persian Bipolar Spectrum Diagnostic Scale at the score of 14, were 0.52, 0.79, 0.81, and 0.49, respectively. The sensitivity and specificity of the parallel application of the Persian Bipolar Spectrum Diagnostic Scale and Mood Disorder Questionnaire were 0.76 and 0.67, respectively.
CONCLUSION: The Persian Bipolar Spectrum Diagnostic Scale and Mood Disorder Questionnaire are useful in screening patients with bipolar disorder in clinical psychiatric settings. Parallel use of both tests seems more effective than either alone.

Entities:  

Mesh:

Year:  2009        PMID: 19111028

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  6 in total

1.  Assessment of the diagnostic performance of two new tools versus routine screening instruments for bipolar disorder: a meta-analysis.

Authors:  Mehdi Sayyah; Ali Delirrooyfard; Fakher Rahim
Journal:  Braz J Psychiatry       Date:  2022 May-Jun

Review 2.  Systematic review reveals heterogeneity in the use of the Scale to Assess Unawareness of Mental Disorder (SUMD).

Authors:  Rémy Dumas; Karine Baumstarck; Pierre Michel; Christophe Lançon; Pascal Auquier; Laurent Boyer
Journal:  Curr Psychiatry Rep       Date:  2013-06       Impact factor: 5.285

3.  The Farsi version of the Hypomania Check-List 32 (HCL-32): applicability and indication of a four-factorial solution.

Authors:  Mohammad Haghighi; Hafez Bajoghli; Jules Angst; Edith Holsboer-Trachsler; Serge Brand
Journal:  BMC Psychiatry       Date:  2011-01-20       Impact factor: 3.630

4.  Iranian mental health survey: design and field proced.

Authors:  Afarin Rahimi-Movaghar; Masoumeh Amin-Esmaeili; Vandad Sharifi; Ahmad Hajebi; Reza Radgoodarzi; Mitra Hefazi; Abbas Motevalian
Journal:  Iran J Psychiatry       Date:  2014-04

5.  Bipolar spectrum disorders and associated factors among adults attending an antiretroviral therapy clinic in Gedeo zone health centers, southern Ethiopia.

Authors:  Zelalem Belayneh; Wagaye Alemu; Birhanie Mekuriaw; Zegeye Abebe
Journal:  Neuropsychiatr Dis Treat       Date:  2019-02-20       Impact factor: 2.570

6.  The Influence of Current Mood States on Screening Accuracy of the Mood Disorder Questionnaire.

Authors:  Hee Ryung Wang; Won-Myong Bahk; Bo-Hyun Yoon; Moon-Doo Kim; Young-Eun Jung; Kyung Joon Min; Jeongwan Hong; Young Sup Woo
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-02-29       Impact factor: 2.582

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.